Fig. 3. Ceramide metabolite levels in 4T1 tumors measured 24 hrs after TA or Sham treatment in combination with GNL or CNL.
a. Ratios of C16 long-chain to C24 very-long-chain ceramide. b. Ratios of C18 long-chain to C24 very-long-chain ceramide. c. Sphingosine-1-phosphate (S1P) levels. For all data sets: n=7–9 and ٭p<0.05.